As Co-Chairs of the 2017 ISPE Process Validation Statistics Conference, we are pleased to invite you to join us in Bethesda, Maryland, 13 – 15 September as we explore evolving and state-of-the-art approaches to implementing statistics in process validation.
This exceptional forum has become a converging point for statisticians and those skilled in the use of statistics to reflect on past practices, discuss current trends, and consider future challenges. You’ll have the opportunity to interact with regulatory experts and leading practitioners as they share their current thoughts on the relationship of statistics, validation decisions, and patient risk.
You will also actively participate in discussion groups exploring current challenges chosen by attendees, and an open forum session on the recent EMA reflection paper on comparability assessment of quality attributes. Dr. Kit Roes, University Medical Center Utrecht, will provide additional insight into this effort in his keynote address.
This year’s conference will expand your knowledge on:
You can also sharpen your process validation knowledge by taking advantage of the 2017 ISPE Process Validation Conference, which takes place right before the Process Validation Statistics Conference. Save an additional 25% by registering for both conferences.
For more information and to register for the 2017 ISPE Process Validation Conference, please visit the conference website.
We look forward to seeing you in September!
Best Regards,
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...